BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $210,000 | +311.8% | 200,000 | +566.7% | 0.08% | +315.8% |
Q2 2019 | $51,000 | -49.5% | 30,000 | 0.0% | 0.02% | -56.8% |
Q1 2019 | $101,000 | +14.8% | 30,000 | 0.0% | 0.04% | 0.0% |
Q4 2018 | $88,000 | -52.4% | 30,000 | 0.0% | 0.04% | -42.1% |
Q3 2018 | $185,000 | -16.3% | 30,000 | 0.0% | 0.08% | -26.2% |
Q2 2018 | $221,000 | +31.5% | 30,000 | +50.0% | 0.10% | +14.4% |
Q4 2017 | $168,000 | -27.3% | 20,000 | 0.0% | 0.09% | -37.1% |
Q3 2017 | $231,000 | -1.3% | 20,000 | 0.0% | 0.14% | -14.4% |
Q2 2017 | $234,000 | -5.3% | 20,000 | 0.0% | 0.17% | -20.1% |
Q1 2017 | $247,000 | – | 20,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |